ACACA
Acetyl-CoA carboxylase 1
Also known as: ACAC, Acac1, ACACA_HUMAN, ACACalpha, ACC, ACC-alpha, ACC1, ACCA, ACCalpha, hACC1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13085
- Gene
- ACACA
- Ensembl
- ENSG00000278540
- Chromosome
- 17
- Canonical length
- 2346 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoli fibrillar center,Actin filaments,Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis. There are two ACC forms, alpha and beta, encoded by two different genes. ACC-alpha is highly enriched in lipogenic tissues. The enzyme is under long term control at the transcriptional and translational levels and under short term regulation by the phosphorylation/dephosphorylation of targeted serine residues and by allosteric transformation by citrate or palmitoyl-CoA. Multiple alternatively spliced transcript variants divergent in the 5' sequence and encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
2346 residues, UniProt reviewed canonical sequence.
>Q13085|ACACA
1 MDEPSPLAQP LELNQHSRFI IGSVSEDNSE DEISNLVKLD LLEEKEGSLS PASVGSDTLS
61 DLGISSLQDG LALHIRSSMS GLHLVKQGRD RKKIDSQRDF TVASPAEFVT RFGGNKVIEK
121 VLIANNGIAA VKCMRSIRRW SYEMFRNERA IRFVVMVTPE DLKANAEYIK MADHYVPVPG
181 GPNNNNYANV ELILDIAKRI PVQAVWAGWG HASENPKLPE LLLKNGIAFM GPPSQAMWAL
241 GDKIASSIVA QTAGIPTLPW SGSGLRVDWQ ENDFSKRILN VPQELYEKGY VKDVDDGLQA
301 AEEVGYPVMI KASEGGGGKG IRKVNNADDF PNLFRQVQAE VPGSPIFVMR LAKQSRHLEV
361 QILADQYGNA ISLFGRDCSV QRRHQKIIEE APATIATPAV FEHMEQCAVK LAKMVGYVSA
421 GTVEYLYSQD GSFYFLELNP RLQVEHPCTE MVADVNLPAA QLQIAMGIPL YRIKDIRMMY
481 GVSPWGDSPI DFEDSAHVPC PRGHVIAARI TSENPDEGFK PSSGTVQELN FRSNKNVWGY
541 FSVAAAGGLH EFADSQFGHC FSWGENREEA ISNMVVALKE LSIRGDFRTT VEYLIKLLET
601 ESFQMNRIDT GWLDRLIAEK VQAERPDTML GVVCGALHVA DVSLRNSVSN FLHSLERGQV
661 LPAHTLLNTV DVELIYEGVK YVLKVTRQSP NSYVVIMNGS CVEVDVHRLS DGGLLLSYDG
721 SSYTTYMKEE VDRYRITIGN KTCVFEKEND PSVMRSPSAG KLIQYIVEDG GHVFAGQCYA
781 EIEVMKMVMT LTAVESGCIH YVKRPGAALD PGCVLAKMQL DNPSKVQQAE LHTGSLPRIQ
841 STALRGEKLH RVFHYVLDNL VNVMNGYCLP DPFFSSKVKD WVERLMKTLR DPSLPLLELQ
901 DIMTSVSGRI PPNVEKSIKK EMAQYASNIT SVLCQFPSQQ IANILDSHAA TLNRKSEREV
961 FFMNTQSIVQ LVQRYRSGIR GHMKAVVMDL LRQYLRVETQ FQNGHYDKCV FALREENKSD
1021 MNTVLNYIFS HAQVTKKNLL VTMLIDQLCG RDPTLTDELL NILTELTQLS KTTNAKVALR
1081 ARQVLIASHL PSYELRHNQV ESIFLSAIDM YGHQFCIENL QKLILSETSI FDVLPNFFYH
1141 SNQVVRMAAL EVYVRRAYIA YELNSVQHRQ LKDNTCVVEF QFMLPTSHPN RGNIPTLNRM
1201 SFSSNLNHYG MTHVASVSDV LLDNSFTPPC QRMGGMVSFR TFEDFVRIFD EVMGCFSDSP
1261 PQSPTFPEAG HTSLYDEDKV PRDEPIHILN VAIKTDCDIE DDRLAAMFRE FTQQNKATLV
1321 DHGIRRLTFL VAQKDFRKQV NYEVDRRFHR EFPKFFTFRA RDKFEEDRIY RHLEPALAFQ
1381 LELNRMRNFD LTAIPCANHK MHLYLGAAKV EVGTEVTDYR FFVRAIIRHS DLVTKEASFE
1441 YLQNEGERLL LEAMDELEVA FNNTNVRTDC NHIFLNFVPT VIMDPSKIEE SVRSMVMRYG
1501 SRLWKLRVLQ AELKINIRLT PTGKAIPIRL FLTNESGYYL DISLYKEVTD SRTAQIMFQA
1561 YGDKQGPLHG MLINTPYVTK DLLQSKRFQA QSLGTTYIYD IPEMFRQSLI KLWESMSTQA
1621 FLPSPPLPSD MLTYTELVLD DQGQLVHMNR LPGGNEIGMV AWKMTFKSPE YPEGRDIIVI
1681 GNDITYRIGS FGPQEDLLFL RASELARAEG IPRIYVSANS GARIGLAEEI RHMFHVAWVD
1741 PEDPYKGYRY LYLTPQDYKR VSALNSVHCE HVEDEGESRY KITDIIGKEE GIGPENLRGS
1801 GMIAGESSLA YNEIITISLV TCRAIGIGAY LVRLGQRTIQ VENSHLILTG AGALNKVLGR
1861 EVYTSNNQLG GIQIMHNNGV THCTVCDDFE GVFTVLHWLS YMPKSVHSSV PLLNSKDPID
1921 RIIEFVPTKT PYDPRWMLAG RPHPTQKGQW LSGFFDYGSF SEIMQPWAQT VVVGRARLGG
1981 IPVGVVAVET RTVELSIPAD PANLDSEAKI IQQAGQVWFP DSAFKTYQAI KDFNREGLPL
2041 MVFANWRGFS GGMKDMYDQV LKFGAYIVDG LRECCQPVLV YIPPQAELRG GSWVVIDSSI
2101 NPRHMEMYAD RESRGSVLEP EGTVEIKFRR KDLVKTMRRV DPVYIHLAER LGTPELSTAE
2161 RKELENKLKE REEFLIPIYH QVAVQFADLH DTPGRMQEKG VISDILDWKT SRTFFYWRLR
2221 RLLLEDLVKK KIHNANPELT DGQIQAMLRR WFVEVEGTVK AYVWDNNKDL AEWLEKQLTE
2281 EDGVHSVIEE NIKCISRDYV LKQIRSLVQA NPEVAMDSII HMTQHISPTQ RAEVIRILST
2341 MDSPSTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACACA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 28 nTPM
- prostate: 25 nTPM
- esophagus: 24 nTPM
- adrenal gland: 24 nTPM
- liver: 23 nTPM
- spinal cord: 22 nTPM
Single-cell type
- choroid plexus epithelial cells: 420 nCPM
- other brain neurons: 329 nCPM
- brain inhibitory neurons: 290 nCPM
- brain excitatory neurons: 279 nCPM
- oligodendrocyte progenitor cells: 260 nCPM
- oligodendrocytes: 260 nCPM
Immune cell
- intermediate monocyte: 1.3 nTPM
- naive B-cell: 1.1 nTPM
- myeloid DC: 1 nTPM
- naive CD4 T-cell: 1 nTPM
- T-reg: 1 nTPM
- classical monocyte: 0.8 nTPM
Brain region
- cerebral cortex: 37 nTPM
- white matter: 29 nTPM
- choroid plexus: 28 nTPM
- hypothalamus: 27 nTPM
- pons: 27 nTPM
- medulla oblongata: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACACA.
Disease | AllUniProt
Conditions ACACA is implicated in, by any mechanism.
- Acetyl-CoA carboxylase-alpha deficiency (ACACAD) MIM:613933
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 462 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Acetyl-CoA: carboxylase deficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 7.24
- DepMap mean gene effect
- -0.38
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acetyl-CoA metabolic process
- cellular response to prostaglandin E stimulus
- fatty acid biosynthetic process
- fatty-acyl-CoA biosynthetic process
- lipid homeostasis
- malonyl-CoA biosynthetic process
- protein homotetramerization
- tissue homeostasis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Biotin/lipoyl attachment
- Biotin-binding site
- Carbamoyl phosphate synthase, ATP-binding domain
- Biotin carboxylase-like, N-terminal domain
- Biotin carboxylase, C-terminal
- Single hybrid motif
- Rudiment single hybrid motif
- ATP-grasp fold
- Acetyl-coenzyme A carboxyltransferase, N-terminal
- Acetyl-coenzyme A carboxyltransferase, C-terminal
- Biotin carboxylation domain
- Acetyl-CoA carboxylase, central domain
- ATP-grasp fold, subdomain 1
- Pre-ATP-grasp domain superfamily
- ClpP/crotonase-like domain superfamily
- Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
- Acetyl-CoA carboxylase, BT domain
- Acetyl-CoA carboxylase
- Biotin carboxylase, N-terminal domain
- Biotin-requiring enzyme
- Carboxyl transferase domain
- Biotin carboxylase C-terminal domain
- Carbamoyl-phosphate synthase L chain, ATP binding domain
- Acetyl-CoA carboxylase, central region
- Acetyl-CoA carboxylase, BT domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ACACA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACACA as an antibody target. Whether an autoantibody or antibody against ACACA could matter depends on whether native ACACA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACACA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACACA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...